Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,155 DKK | -3.73% | -4.53% | -13.14% |
Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
Feb. 21 | Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI). | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-13.14% | 6.18M | |
+1.10% | 106B | |
+9.29% | 103B | |
-2.30% | 21.44B | |
-11.89% | 22.11B | |
-26.59% | 20.99B | |
-5.80% | 19.44B | |
-6.58% | 17.6B | |
+5.83% | 13.88B | |
+7.46% | 11.75B |
- Stock
- Equities
- Stock Orphazyme A/S - Nasdaq Copenhagen
- News Orphazyme A/S
- Orphazyme A/S : European ADRs Move Higher in Thursday Trading